Cellink Competitors and Similar CompaniesClear all

Cellink's competitors and similar companies include inviCRO and Autolus.
Cellink
Cellink
CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.
inviCRO
inviCRO
inviCRO provides a suite of services and software for medical imaging analysis.
Autolus
Autolus
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
Founding Date
Founding Date
2016
Founding Date
2008
Founding Date
2014
Type
Type
Subsidiary
Type
Private
Type
Public
Tags
Locations
Locations
Göteborg, SE HQ
Dardilly, FR
Kyoto, JP
Göteborg, SE
Brighton, GB
Blacksburg, US
Boston, US
Locations
Boston, US HQ
London, GB
Doylestown, US
New Haven, US
New Haven, US
Locations
London, GB HQ
London, GB
Employees
Employees
851% decrease
Employees
1485% decrease
Employees
647

Financial

Revenue (est.)
Revenue (est.)
kr74.2m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$75.4m (FY, 2025)
Cost of goods
Cost of goods
kr40.2m (FY, 2021)
Cost of goods
N/A
Cost of goods
$86.6m (FY, 2025)
Gross profit
Gross profit
kr34.1m (FY, 2021)
Gross profit
N/A
Gross profit
($10.7m) (FY, 2025)
Net income
Net income
(kr27.4m) (FY, 2021)
Net income
N/A
Net income
($287.5m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 4.1m
Total funding raised
$ 45.8m
Total funding raised
$ 281.7m
For sources of this data, please see the company profile

View Company Profiles

inviCRO
HQ
Boston, US
Employees
148↓ 5% decrease

inviCRO provides a suite of services and software for medical imaging analysis.

View company
Autolus
HQ
London, GB
Employees
647

Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.

View company